TY - JOUR
T1 - Calcium signaling is dispensable for receptor regulation of endothelial barrier function
AU - Stolwijk, Judith A.
AU - Zhang, Xuexin
AU - Gueguinou, Maxime
AU - Zhang, Wei
AU - Matrougui, Khalid
AU - Renken, Christian
AU - Trebak, Mohamed
N1 - Funding Information:
This work was supported by American Heart Association Grant 14GRNT18880008, National Institutes of Health Grants R01HL097111 and R01HL123364 (to M. T.) and R01HL095566 (to K. M.), and in part by a postdoctoral fellowship from Applied Biophysics Inc. (to J. A. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
PY - 2016/10/28
Y1 - 2016/10/28
N2 - Endothelial barrier function is tightly regulated by plasma membrane receptors and is crucial for tissue fluid homeostasis; its dysfunction causes disease, including sepsis and inflammation. The ubiquitous activation of Ca 2+ signaling upon phospholipase C-coupled receptor ligation leads quite naturally to the assumption that Ca 2+ signaling is required for receptor-regulated endothelial barrier function. This widespread hypothesis draws analogy from smooth muscle and proposes the requirement of G protein-coupled receptor (GPCR)-generated Ca 2+ signaling in activating the endothelial contractile apparatus and generating interendothelial gaps. Notwithstanding endothelia being non-excitable in nature, the hypothesis of Ca 2+ -induced endothelial contraction has been invoked to explain actions of GPCR agonists that either disrupt or stabilize endothelial barrier function. Here, we challenge this correlative hypothesis by showing a lack of causal link between GPCR-generated Ca 2+ signaling and changes in human microvascular endothelial barrier function. We used three endogenous GPCR agonists: thrombin and histamine, which disrupt endothelial barrier function, and sphingosine-1-phosphate, which stabilizes barrier function. The qualitatively different effects of these three agonists on endothelial barrier function occur independently of Ca 2+ entry through the ubiquitous store-operated Ca 2+ entry channel Orai1, global Ca 2+ entry across the plasma membrane, and Ca 2+ release from internal stores. However, disruption of endothelial barrier function by thrombin and histamine requires the Ca 2+ sensor stromal interacting molecule-1 (STIM1), whereas sphingosine-1-phosphate-mediated enhancement of endothelial barrier function occurs independently of STIM1. We conclude that although STIM1 is required for GPCR-mediated disruption of barrier function, a causal link between GPCR-induced cytoplasmic Ca2+ increases and acute changes in barrier function is missing. Thus, the cytosolic Ca 2+ -induced endothelial contraction is a cum hoc fallacy that should be abandoned.
AB - Endothelial barrier function is tightly regulated by plasma membrane receptors and is crucial for tissue fluid homeostasis; its dysfunction causes disease, including sepsis and inflammation. The ubiquitous activation of Ca 2+ signaling upon phospholipase C-coupled receptor ligation leads quite naturally to the assumption that Ca 2+ signaling is required for receptor-regulated endothelial barrier function. This widespread hypothesis draws analogy from smooth muscle and proposes the requirement of G protein-coupled receptor (GPCR)-generated Ca 2+ signaling in activating the endothelial contractile apparatus and generating interendothelial gaps. Notwithstanding endothelia being non-excitable in nature, the hypothesis of Ca 2+ -induced endothelial contraction has been invoked to explain actions of GPCR agonists that either disrupt or stabilize endothelial barrier function. Here, we challenge this correlative hypothesis by showing a lack of causal link between GPCR-generated Ca 2+ signaling and changes in human microvascular endothelial barrier function. We used three endogenous GPCR agonists: thrombin and histamine, which disrupt endothelial barrier function, and sphingosine-1-phosphate, which stabilizes barrier function. The qualitatively different effects of these three agonists on endothelial barrier function occur independently of Ca 2+ entry through the ubiquitous store-operated Ca 2+ entry channel Orai1, global Ca 2+ entry across the plasma membrane, and Ca 2+ release from internal stores. However, disruption of endothelial barrier function by thrombin and histamine requires the Ca 2+ sensor stromal interacting molecule-1 (STIM1), whereas sphingosine-1-phosphate-mediated enhancement of endothelial barrier function occurs independently of STIM1. We conclude that although STIM1 is required for GPCR-mediated disruption of barrier function, a causal link between GPCR-induced cytoplasmic Ca2+ increases and acute changes in barrier function is missing. Thus, the cytosolic Ca 2+ -induced endothelial contraction is a cum hoc fallacy that should be abandoned.
UR - http://www.scopus.com/inward/record.url?scp=84994017693&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84994017693&partnerID=8YFLogxK
U2 - 10.1074/jbc.M116.756114
DO - 10.1074/jbc.M116.756114
M3 - Article
C2 - 27624938
AN - SCOPUS:84994017693
SN - 0021-9258
VL - 291
SP - 22894
EP - 22912
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 44
ER -